Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06151106	Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma	recruiting	Phase 2	33	The First Affiliated Hospital of Xiamen UniversityOTHER	1	Feb 19, 2025	clinicaltrials
NCT06824883	Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma	recruiting	Phase 2	49	Peking Union Medical College HospitalOTHER	1	Feb 13, 2025	clinicaltrials